what is a glp 1 program GLP-1 Agonists: Comprehensive Overview GLP-1 Drug Savings: A Complete
Description
Archived from the original on 3 July 2022
BMJ Open Gastroenterol
Proper monitoring is extremely important
Medicare is legally prohibited from covering weight-loss prescriptions, contributing to just 1% usage among adults 65 and older
Patients should maintain adequate fluid intake based on individual needs, with the goal of maintaining pale yellow urine color
These incretin effects explain the initially surprising weight loss observed in the treatment groups of the cardiovascular trials, with subjects taking GLP-1/GIP agonists losing from 3% to 12% of their body weight
